Clinical Trial

REGULUS: MRI-guided Adaptive SABR for Liver Cancers

Name: REGULUS: MRI-guided Adaptive SABR for Liver Cancers — clinical trial record (NCT07223307)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Single arm unblinded study of simulation-free MRI-guided SABR with adaptive replanning in one session for treatment of patients with liver cancers

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-10-28; most recent amendment 2026-02-05.

Status change: Not Yet Recruiting → Recruiting 2026-01-23

Trial Details

NCT Number	NCT07223307
Lead Sponsor	Stanford University Collaborators: Viewray Inc.
Conditions	Liver Cancer, Intrahepatic Cholangiocarcinoma, Liver Metastases, HCC
Enrollment	62 participants
Start Date	2026-01-23
Primary Completion	2030-01 (estimated)
Study Completion	2030-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-09